| Rank | Ticker | Country | Price | Revenue | Analyst Rating | Analysts | IPO Year |
|---|---|---|---|---|---|---|---|
#1 | MMED | United States | $10.89 | $0.00 | Strong Buy | 10 | 2026 |
#2 | PAYP | Japan | $19.36 | $0.00 | Buy | 9 | 2026 |
#3 | LYFT | United States | $13.05 | $6,316,261,000.00 | Buy | 29 | 2019 |
#4 | WAY | United States | $18.12 | $1,099,278,000.00 | Strong Buy | 17 | 2023 |
#5 | VRRM | United States | $13.10 | $132,969,000.00 | Buy | 5 | 2016 |
#6 | TBPH | United States | $16.32 | $15,386,000.00 | Buy | 6 | 2013 |
#7 | EYE | United States | $17.53 | $1,987,488,000.00 | Strong Buy | 9 | 2017 |
#8 | AMRX | United States | $11.92 | $0.00 | Strong Buy | 5 | 2018 |
#9 | BXMT | United States | $18.09 | $0.00 | Buy | 5 | 1998 |
#10 | KROS | United States | $10.39 | $243,864,000.00 | Buy | 7 | 2020 |
#11 | HLMN | United States | $7.18 | $1,552,224,000.00 | Strong Buy | 5 | 2020 |
#12 | NMRK | United States | $14.34 | $3,294,024,000.00 | Buy | 5 | 2017 |
#13 | ALHC | United States | $15.83 | $3,948,719,000.00 | Buy | 8 | 2021 |
#14 | OMER | United States | $12.19 | $29,868,000.00 | Strong Buy | 5 | 2008 |
#15 | WWW | United States | $15.39 | $1,874,300,000.00 | Buy | 10 | 2002 |
#16 | CERT | United States | $4.50 | $418,838,000.00 | Buy | 10 | 2020 |
#17 | NRDS | United States | $7.77 | $836,600,000.00 | Buy | 5 | 2021 |
#18 | AMLX | United States | $13.23 | $380,786,000.00 | Strong Buy | 9 | 2021 |
#19 | ADPT | United States | $12.91 | $276,976,000.00 | Strong Buy | 9 | 2019 |
#20 | AZTA | United States | $16.06 | $593,821,000.00 | Strong Buy | 5 | 1996 |
#21 | ARVN | United States | $9.09 | $262,600,000.00 | Buy | 19 | 2018 |
#22 | STTK | United States | $6.27 | $1,000,000.00 | Buy | 7 | 2020 |
#23 | CRVS | United States | $12.32 | $0.00 | Strong Buy | 6 | 2016 |
#24 | RLMD | United States | $6.92 | $13,070.00 | Strong Buy | 5 | 2012 |
#25 | REAL | United States | $9.05 | $692,845,000.00 | Buy | 8 | 2019 |
#26 | LXEO | United States | $5.07 | $654,000.00 | Strong Buy | 9 | 2023 |
#27 | CRTO | France | $16.04 | $2,296,692,000.00 | Strong Buy | 10 | 2013 |
#28 | ERAS | United States | $10.21 | $0.00 | Strong Buy | 12 | 2021 |
#29 | RIVN | United States | $13.86 | $5,387,000,000.00 | Buy | 21 | 2021 |
#30 | OBIO | United States | $3.76 | $33,482,000.00 | Strong Buy | 5 | 2020 |
#31 | SBH | United States | $11.93 | $3,701,424,000.00 | Buy | 6 | 2006 |
#32 | RLAY | United States | $12.27 | $15,355,000.00 | Strong Buy | 10 | 2020 |
#33 | ADCT | Switzerland | $3.26 | $81,357,000.00 | Strong Buy | 4 | 2019 |
#34 | MRBK | United States | $17.14 | $6,316,000.00 | Strong Buy | 4 | 2018 |
#35 | ENTA | United States | $13.42 | $102,814,000.00 | Strong Buy | 5 | 2012 |
#36 | NPCE | United States | $15.25 | $99,986,000.00 | Strong Buy | 6 | 2021 |
#37 | RYN | United States | $19.81 | $484,485,000.00 | Buy | 4 | 1994 |
#38 | MAX | United States | $8.05 | $1,113,600,000.00 | Buy | 5 | 2020 |
#39 | FHTX | United States | $3.77 | $30,909,000.00 | Strong Buy | 8 | 2020 |
#40 | RVLV | United States | $18.55 | $1,225,682,000.00 | Buy | 12 | 2018 |
#41 | FNB | United States | $17.10 | $0.00 | Strong Buy | 5 | 2002 |
#42 | VITL | United States | $8.43 | $759,444,000.00 | Buy | 11 | 2020 |
#43 | ORIC | United States | $8.16 | $0.00 | Strong Buy | 13 | 2020 |
#44 | FDMT | United States | $9.19 | $85,209,000.00 | Strong Buy | 7 | 2019 |
#45 | RGNX | United States | $5.71 | $10,393,000.00 | Strong Buy | 8 | 2015 |
#46 | VSTM | United States | $4.33 | $30,914,000.00 | Strong Buy | 7 | 2011 |
#47 | VIR | United States | $8.74 | $68,556,000.00 | Strong Buy | 7 | 2019 |
#48 | OLMA | United States | $13.47 | $0.00 | Strong Buy | 10 | 2020 |
#49 | DBVT | France | $19.52 | $5,636,000.00 | Buy | 7 | 2014 |
#50 | FCF | United States | $18.05 | $0.00 | Buy | 4 | 1994 |
The FinQuota filters have identified what they believe to be the "Best Stocks Under $20 to Buy (May 16, 2026) | FinQuota" to buy now. However, please note that this information should not be considered as financial advice, as investing involves risks. We strongly recommend consulting with a qualified financial advisor before making any decisions regarding buying or selling stocks.